目录产品 » 多肽产品 » 多肽产品搜索 » LL37 (Human)
Manual
COAs
HPLC
MS

LL37 (Human)

The cathelicidin anti-microbial peptide LL-37 is involved in the reepithelialization of human skin wounds and is lacking in chronic ulcer epithelium. LL-37(human) is a cathelicidin-derived peptide with antimicrobial and angiogenic activity.
￥1700 在线订购包邮(港澳台除外)
RP13323

咨询产品问题
产品概述
Description The cathelicidin anti-microbial peptide LL-37 is involved in the reepithelialization of human skin wounds and is lacking in chronic ulcer epithelium. LL-37(human) is a cathelicidin-derived peptide with antimicrobial and angiogenic activity.
Sequence
{LEU}{LEU}{GLY}{ASP}{PHE}{PHE}{ARG}{LYS}{SER}{LYS}{GLU}{LYS}
{ILE}{GLY}{LYS}{GLU}{PHE}{LYS}{ARG}{ILE}{VAL}{GLN}{ARG}{ILE}
{LYS}{ASP}{PHE}{LEU}{ARG}{ASN}{LEU}{VAL}{PRO}{ARG}{THR}{GLU}
{SER}
Sequence Shortening LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
Molecular Formula C205H340N60O53
Molecular Weight 4493.28
返回

产品属性
Purity > 95%
Solubility Soluble in Ultrapure water under 1mg/ml
Form Lyophilized
Storage Store the product at -20°C. Keep container tightly closed. Store in a cool dry place.
返回

相关文献
Hanlin Zhang, et al. Recombinant Lactococcus lactis Expressing Human LL-37 Prevents Deaths from Viral Infections in Piglets and Chicken. Probiotics Antimicrob Proteins. (2023-09)
MengDong, et al. Preliminary evaluation of the safety and efficacy of oral human antimicrobial peptide LL-37 in the treatment of patients of COVID-19, a small-scale, single-arm, exploratory safety study. medrxiv. (2020-05)